Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (IT:1CVS)
:1CVS
Holding IT:1CVS?
Track your performance easily
1CVS Stock Chart & Stats
Day’s Range― - ―
52-Week Range€41.40 - €73.84
Previous CloseN/A
Volume0.00
Average Volume (3M)197.00
Market Cap
$64.48B
Enterprise Value€152.29B
Total Cash (Recent Filing)$6.58B
Total Debt (Recent Filing)$90.28B
Price to Earnings (P/E)14.3
BetaN/A
Next Earnings
Feb 12, 2025EPS Estimate
0.88Last Dividend Ex-Date
Jan 23, 2025Dividend Yield4.88%
Share Statistics
EPS (TTM)3.65
Shares Outstanding1,258,407,600
10 Day Avg. Volume164
30 Day Avg. Volume197
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.18
Price to Cash Flow (P/CF)-22.70
P/FCF Ratio0.00
Enterprise Value/Market Cap2.36
Enterprise Value/Revenue0.41
Enterprise Value/Gross Profit2.80
Enterprise Value/Ebitda17.07
Forecast
1Y Price Target
€61.15Price Target Upside13.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
CVS Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCVS is well positioned to execute on improved profitability through significant contributions from Medicare Advantage Star ratings bonus payments, operational cost savings, and removing coverage of dental implants.
Market PositionCVS shares trade at a low valuation, offering potential upside as the company is positioned for growth despite current earnings challenges.
Operational StrategyThe adoption of CostVantage and potential Cordavis product launches could support further upside to earnings, driven by improved reimbursement pressure and transparency.
Bears Say
Financial PerformanceThe price target has been lowered from $57.00 to $51.00 to account for incremental uncertainty.
Pharmacy Benefit Manager ReformsNegative sentiment around pharmacy benefit manager reforms may persist, impacting the company's valuation.
Regulatory ChallengesOpioids have resurfaced as a result of recent NY Times coverage and a DOJ lawsuit against CVS.
---
Ownership Overview
1.04% Insiders
28.35% Mutual Funds
0.15% Other Institutional Investors
49.83% Public Companies and Individual Investors
Website Traffic
The estimated number of people who visited one or more of the websites owned by CVS Health
Desktop Users
Mobile Users
1CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €41.40 and its highest was €73.84 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $64.48B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Feb 12, 2025 which is in 12 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Nov 06, 2024. The company reported €1.043 earnings per share for the quarter, missing the consensus estimate of €1.374 by -€0.331.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of €0.633 which represents an annual dividend yield of 4.88%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 0.88.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,258,407,600 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of €1.043 in its last earnings report, missing expectations of €1.374. Following the earnings report the stock price went up 13.577%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in IT:1CVS
---
CVS Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€61.15 (13.05% Upside)
€61.15 (13.05% Upside)
Blogger Sentiment
Bullish
IT:1CVS Sentiment 77%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.12%
12-Months-Change
Fundamentals
Return on Equity
6.72%
Trailing 12-Months
Asset Growth
0.45%
Trailing 12-Months
Company Description
CVS Health Corp
Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.
---
1CVS Company Deck
---
1CVS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging environment with significant issues in the Health Care Benefits segment, including elevated utilization and mispricing in Medicare and individual exchange products. However, there are strong performances in the Pharmacy and Consumer Wellness, Health Services, and Health Care Delivery segments, driving optimism for future growth.Read More>---
1CVS Revenue Breakdown
52.22% Health Services
32.64% Pharmacy & Consumer Wellness
29.53% Health Care Benefits
0.13% Corporate/ Other
---
1CVS Stock 12 Month Forecast
Average Price Target
€61.15
▲(13.05% Upside)
Technical Analysis
Best Analysts Covering 1CVS
1 Year
1 Year Success Rate
15/28 ratings generated profit
1 Year Average Return
+4.23%
reiterated a buy rating 9 months ago
Copying John Ransom's trades and holding each position for 1 Year would result in 53.57% of your transactions generating a profit, with an average return of +4.23% per trade.
---